BioSputnik LLC is a pharmaceutical company based in New York, New York, specializing in the development and distribution of medicinal products. Situated at 504 Grand Street in the 10002 postal area, the company operates within the bustling pharmaceutical industry of New York City, contributing to the region’s healthcare sector. Its focus lies in creating solutions that address various medical needs, leveraging scientific research and innovation to support patient care.
As a pharmaceutical company, BioSputnik LLC engages in the complex process of drug development, which encompasses formulation, testing, and regulatory compliance. The company works closely with healthcare professionals and institutions to ensure that its products meet stringent safety and efficacy standards. Located in one of the nation’s leading hubs for medical research, BioSputnik benefits from proximity to academic and clinical resources that enhance its capacity for pharmaceutical innovation.
In addition to product development, BioSputnik LLC emphasizes the importance of quality control and manufacturing practices, adhering to industry regulations to maintain product integrity. The company’s operations include the management of supply chains and distribution networks to facilitate the timely delivery of pharmaceutical products to pharmacies, hospitals, and clinics within the New York metropolitan area. This integrated approach supports the availability of essential medications to the local community.
BioSputnik LLC’s role in the pharmaceutical landscape reflects a commitment to advancing healthcare through scientific progress and responsible business practices. Its presence in New York City situates the company at the crossroads of research, development, and patient care, enabling it to respond to emerging health challenges and contribute to the overall improvement of public health outcomes.


































